Friday, July 31, 2026

Samsung Launches New Mini-Organ Tech to Speed Up Cancer Drug Testing

Samsung Biologics launches Samsung Organoids for drug screening, focusing on anticancer candidates to enhance precision and reduce costs.

6G Preview? KT Demonstrates AI-Driven CSI Compression on a Qualcomm Snapdragon Platform, Boosting Downlink by ~50%

KT demonstrates AI-based wireless tech with Qualcomm and Rohde & Schwarz, improving downlink speeds by 50% for next-gen networks.

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Tag: home screen redesign

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.